Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
IMIDACLOPRID, PERMETHRIN
Bayer Limited
QP53AC54
IMIDACLOPRID, PERMETHRIN
Unknown
Spot On Solution
POM
Canine
Permethrin, combinations
Ectoparasiticide
Authorised
2004-04-02
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Advantix Spot-on solution for dogs over 10 kg up to 25 kg. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Spot-on solution. Clear yellowish to brownish solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs (over 10 kg up to 25 kg). For dogs less than or equal to 10 kg or more than 25 kg body weight, use the appropriate Advantix Spot-on solution product (see section 4.9). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment and prevention of flea (_Ctenocephalides canis_,_ Ctenocephalides felis_) infestation. Fleas on dogs are killed within one day following treatment. One treatment prevents further flea infestation for four weeks. The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For the treatment of biting lice (_Trichodectes canis_). The product has persistent acaricidal and repellent efficacy against tick infestations (_Rhipicephalus sanguineus_ and _Ixodes ricinus_ for four weeks, and_ Dermacentor recticulatus_ for three weeks)_._ Ticks already on the dog may not be killed within two days after treatment and may remain attached and visible. Therefore the removal of ticks already on the dog at the time of treatment is recommended, in order to prevent them from attaching and having a blood meal. One treatment provides repellent (anti-feeding) activity against sand flies (_Phlebotomus papatasi_ for two weeks and _Phlebotomus pernicious_ for three weeks), against mosquitoes (_Aedes aegypti_ for two weeks and_ Culex pipiens_ for four weeks) and against stable flies (_Stomoxys calcitrans_) for four weeks. ACTIVE SUBSTANCES: Imidacloprid 100 mg/ml Permethrin: 500 mg/ml EXCIPIENT(S): Butylhydroxytoluene (E321): 1.0 mg/ml For a full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ Прочетете целия документ